MONDAY, JUNE 17 | 5:30 – 8:30 PM


The course will discuss a series of 3D bioprinting strategies for use in the fabrication of various physiologically or pathologically relevant human tissue models to achieve improved drug screening and personalized medicine. New advances in extrusion and stereolithographic bioprinting as well as bioink designs will be presented, along with exemplary applications in drug testing using different types of bioprinted tissue models.


  • Basic principles of bioprinting.
  • Different strategies in bioprinting.
  • Methods for 3D tissue model fabrication using bioprinting.
  • Usage of 3D tissue models in drug screening.


The Age of Applications in 3D Bioprinting

Taciana Pereira, Director of Bioengineering, Allevi, Inc.

Ricky Solorzano, CEO, Allevi, Inc.

Biology exists in 3D, but it is most often studied in oversimplified 2D experiments. Extrusion bioprinting offers a series of standardized, automated, and high-throughput methods that allow for the creation of relevant 3D models within tissue engineering and pharmacology. This presentation will review the key bioprinting methods that are empowering researchers around the world.

Putting 3D Bioprinting to the Use of Tissue Model Fabrication

Yu Shrike Zhang, PhD, Assistant Professor & Associate Bioengineer, Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School

This short course will discuss a series of bioprinting strategies that we have developed, including sacrificial bioprinting, microfluidic bioprinting, and multi-material bioprinting, along with various cytocompatible bioink formulations, for the fabrication of biomimetic organoids. These platform technologies will likely provide new opportunities in constructing functional tissue models with a potential application in clinical therapeutics and precision therapy.


Pereira_TacianaTaciana Pereira, Director of Bioengineering, Allevi, Inc.

Taciana Pereira is the Director of Bioengineering at Allevi Inc., where she leads bioink development for the fabrication of custom 3D tissues and facilitates pharmaceutical collaborations. Originally from Curitiba, Brazil, Taciana has a B.Sc. in bioengineering from Harvard University, where she worked at the Wyss Institute for Biologically Inspired Engineering under the advisory of David Mooney (PhD).

Solorzano_RickyRicky Solorzano, CEO, Allevi, Inc.

Ricky Solorzano as the CEO of Allevi guides the vision, strategy, and day-to-day operation. He has been obsessed with tissue engineering for 8 years, created the first desktop 3D bioprinter out of his dorm room, and has been a Forbes “30 under 30”, Inc. “30 under 30”, and Business Insider “100: The Creators #65.”

Zhang_Yu_ShrikeYu Shrike Zhang, PhD, Assistant Professor & Associate Bioengineer, Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School

Dr. Zhang received his PhD from Georgia Institute of Technology in the Wallace H. Coulter Department of Biomedical Engineering. He is currently a Research Faculty at Harvard Medical School and Associate Bioengineer at the Brigham and Women’s Hospital in the Division of Engineering in Medicine. He is also affiliated with the Harvard-MIT Division of Health Sciences and Technology. Dr. Zhang’s research is focused on innovating medical engineering technologies to recreate functional biomimetic tissues, including 3D bioprinting, organs-on-chips, medical devices, biomedical imaging, and biosensing. In collaboration with a multidisciplinary team encompassing biomedical, mechanical, electrical, and computer engineers as well as biologists and clinicians, his laboratory seeks to ultimately translate these cutting-edge technologies into the clinics. More information can be found on his website (